Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Preparation method of intermediate of medicine for treating chronic dry eye

An intermediate and technology for dry eye syndrome, which is applied in the preparation of dry eye drug ritazast intermediate, in the field of dry eye drug intermediates, can solve problems such as high cost, polyphosphorous by-products, and serious environmental pollution. Achieving low cost, high yield and high purity

Inactive Publication Date: 2018-08-31
刘可
View PDF5 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The existing benzofuran-6-carboxylic acid intermediate usually has the following two routes: 1. With 3-bromophenol as raw material, 6-bromobenzofuran is obtained by ring closure, and then reacted with CO under Pd catalysis 2 Coupling to obtain the target compound, the route is short, but ring formation will inevitably produce isomers, which cannot be amplified; Reaction to get [2-(1,3-dioxolan-2-yl) ethyl] diethyl phosphonate, then react with furan-2-carbaldehyde to get (E)-2-[( 1,3-dioxolan-2-yl)methyl]-3-(furan-2-yl)ethyl acrylate, and then cyclized to obtain ethyl benzofuran-6-carboxylate, which was subjected to alkali hydrolysis and acidification That’s right; the cost of this route is relatively high, and more phosphorus by-products will be produced, which will seriously pollute the environment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of intermediate of medicine for treating chronic dry eye

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0014] The preparation method of the dry eye medicine intermediate of the present invention, such as figure 1 As shown, including the following steps:

[0015] (a) Add 2L of methanol, 200g of meta-hydroxybenzoic acid, 61g of NaOH and 226g of NaI to a 5L three-necked flask, add 1.43L of NaClO aqueous solution (mass content of 9%, dropping rate of 2L / h) and control the temperature to -10 ℃~-5℃, react for 2h; Concentrate under reduced pressure at 50℃ to remove methanol, then adjust pH to about 1 with 1N (i.e. equivalent concentration) hydrochloric acid. At this time, a large amount of white solid precipitates, filtered and dried to obtain 280g of compound II; The NMR spectrum of compound II is resolved as: 1 H NMR(400MHz, DMSO-d 6 )δ(ppm): 13.00 (brs, 1H), 10.67 (brs, 1H), 7.78 (d, J = 8.0 Hz, 1H), 7.40 (brs, 1H), 7.11 (d, J = 8.0 Hz, 1H) . ESI-MS m / z calcd:C 7 H 5 IO 3 ([M-H] - ); 262.93, found: 262.9.

[0016] (b) Add 1L of THF (ie tetrahydrofuran) to a 3L three-necked flask, and...

Embodiment 2

[0019] This example provides a method for preparing a dry eye syndrome drug intermediate, which is basically the same as that in Example 1, except that in step (c), 2.2 g of cuprous iodide and 22 g of triethylamine are used Finally, 37.2 g of a yellow solid compound (purity 99.3%) was obtained.

Embodiment 3

[0021] This embodiment provides a method for preparing a dry eye syndrome drug intermediate, which is basically the same as that in Example 1, except that: in step (c), 1.8g cuprous iodide and 18g triethylamine are used Finally, 36.5 g of a yellow solid compound (purity 99.2%) was obtained.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a preparation method of an intermediate of a medicine for treating chronic dry eye. The method comprises the following steps: (a) adding methyl alcohol, m-hydroxybenzoic acid,NaOH and NaI to a reaction vessel; and dropwise adding NaClO water solution with stirring in order to react under the temperature of -10 to -5 DEG C; (b) adding tetrahydrofuran, a compound II, a catalyst and trimethylamine to another reaction vessel; dropwise adding trimethylsilylacetylene under inert gas; and stirring to react; and (c) adding methyl alcohol, a compound III, cuprous iodide and trimethylamine to a third reaction vessel; reacting under the temperature of 50-80 DEG C; filtering; collecting filtrate; dropwise adding NaOH solution; stirring to react; removing methyl alcohol and trimethylamine in a pressure reduction manner; regulating pH through an acid solution; filtering; and drying to obtain the product. According to the method, the finished product can be prepared by threesteps; the yield and the purity are high; the cost is low; and industrial production can be carried out.

Description

Technical field [0001] The invention belongs to the field of pharmaceutical intermediates, and relates to a dry eye syndrome drug intermediate, in particular to a preparation method of a dry eye syndrome drug Ritamilast intermediate. Background technique [0002] Lipalast (ie Lifitegrast) can bind to integrin lymphocyte function associated antigen-1 (LFA-1), a cell surface protein found on the surface of white blood cells and blocking its associated ligand intracellular adhesion molecule-1 ( ICAM-1), and then ICAM-1 expression in cornea and conjunctival tissues in dry eye disease. [0003] Benzofuran-6-carboxylic acid (CAS: 77095-51-3) is a key intermediate for the formation of tadilast. The existing benzofuran-6-carboxylic acid intermediates usually have the following two routes: 1. Using 3-bromophenol as a raw material, the ring is closed to obtain 6-bromobenzofuran, which is then combined with CO under Pd catalysis. 2 Coupling to obtain the target compound, this route is short,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D307/79
CPCC07D307/79
Inventor 刘可
Owner 刘可
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products